Condensed Consolidated Statement of Noncontrolling Interests and Equity - USD ($) $ in Thousands	Total	Series D Units	Redemption of Operating Partnership units for cash	Redemption of Operating Partnership units for cash Series B Units	Redemption Of Units For Common Stock Series A Units	Redemption Of Units For Common Stock Series D Units	Noncontrolling Interest - Preferred Operating Partnership	Noncontrolling Interest - Preferred Operating Partnership Series D Units	Noncontrolling Interest - Preferred Operating Partnership Redemption of Operating Partnership units for cash Series B Units	Noncontrolling Interest - Preferred Operating Partnership Redemption Of Units For Common Stock Series A Units	Noncontrolling Interest - Preferred Operating Partnership Redemption Of Units For Common Stock Series D Units	Noncontrolling Interest - Operating Partnership	Noncontrolling Interest - Operating Partnership Redemption of Operating Partnership units for cash	Noncontrolling Interest - Other	Common Stock	Common Stock Redemption Of Units For Common Stock Series A Units	Common Stock Redemption Of Units For Common Stock Series D Units	Additional Paid-in Capital	Additional Paid-in Capital Redemption of Operating Partnership units for cash	Additional Paid-in Capital Redemption Of Units For Common Stock Series A Units	Additional Paid-in Capital Redemption Of Units For Common Stock Series D Units	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance, beginning of period at Dec. 31, 2021	$ 3,785,976						$ 259,110					$ 410,053		$ 317	$ 1,339			$ 3,285,948				$ (42,546)	$ (128,245)
Balance, beginning of period (in shares) at Dec. 31, 2021															133,922,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)															180,800
Issuance of common stock in connection with share based compensation	9,789														$ 2			9,787
Restricted stock grants cancelled (in shares)															(7,901)
Redemption of operating partnership units			$ (3,504)	$ (4,500)					$ (4,500)				$ (1,125)						$ (2,379)
Operating Partnership units in conjunction with business combinations (in shares)	16,000	$ 6,000						$ 6,000				16,000
Issuance of common stock in conjunction with acquisitions (in shares)															186,766
Issuance of common stock in conjunction with acquisitions	40,963														$ 2			40,961
Repurchase of common stock, net of offering costs (in shares)															381,786
Repurchase of common stock, net of offering costs	(63,008)														$ (4)								(63,004)
Net income	465,551						8,824					21,018											435,709
Other comprehensive income	71,762						433					3,228										68,101
Distributions to Operating Partnership units held by noncontrolling interests	(28,238)						(8,636)					(19,602)
Dividends paid on common stock	(403,551)																						(403,551)
Balance, end of period at Jun. 30, 2022	3,893,240						261,231					429,572		317	$ 1,339			3,334,317				25,555	(159,091)
Balance, end of period (in shares) at Jun. 30, 2022															133,900,184
Balance, beginning of period at Dec. 31, 2021	$ 3,785,976						259,110					410,053		317	$ 1,339			3,285,948				(42,546)	(128,245)
Balance, beginning of period (in shares) at Dec. 31, 2021															133,922,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock, net of offering costs (in shares)	(381,786)
Repurchase of common stock, net of offering costs	$ (63,008)
Balance, end of period at Dec. 31, 2022	$ 4,078,274						261,502					556,095		1,080	$ 1,339			3,345,332				48,798	(135,872)
Balance, end of period (in shares) at Dec. 31, 2022	133,921,020														133,921,020
Balance, beginning of period at Mar. 31, 2022	$ 3,878,164						256,051					411,581		317	$ 1,343			3,329,608				6,457	(127,193)
Balance, beginning of period (in shares) at Mar. 31, 2022															134,251,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)															38,016
Issuance of common stock in connection with share based compensation	5,245																	5,245
Restricted stock grants cancelled (in shares)															(7,122)
Redemption of operating partnership units			$ (832)	$ (1,125)					$ (1,125)				$ (296)						$ (536)
Operating Partnership units in conjunction with business combinations (in shares)	16,000	$ 6,000						$ 6,000				16,000
Repurchase of common stock, net of offering costs (in shares)															(381,786)
Repurchase of common stock, net of offering costs	(63,008)														$ (4)								(63,004)
Net income	247,834						4,491					11,213											232,130
Other comprehensive income	20,113						120					895										19,098
Distributions to Operating Partnership units held by noncontrolling interests	(14,127)						(4,306)					(9,821)
Dividends paid on common stock	(201,024)																						(201,024)
Balance, end of period at Jun. 30, 2022	3,893,240						261,231					429,572		317	$ 1,339			3,334,317				25,555	(159,091)
Balance, end of period (in shares) at Jun. 30, 2022															133,900,184
Balance, beginning of period at Dec. 31, 2022	$ 4,078,274						261,502					556,095		1,080	$ 1,339			3,345,332				48,798	(135,872)
Balance, beginning of period (in shares) at Dec. 31, 2022	133,921,020														133,921,020
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)															143,387
Issuance of common stock in connection with share based compensation	$ 12,439														$ 2			12,437
Taxes paid upon settlement of share based compensation (in shares)															(7,660)
Taxes paid upon net settlement of share based compensation	(7,543)																	(7,543)
Restricted stock grants cancelled (in shares)															(3,855)
Redemption of Operating Partnership units (in shares)																851,698	154,307
Redemption of operating partnership units					$ (5,316)	$ 0				$ (16,339)	$ (22,064)					$ 8	$ 2			$ 11,015	$ 22,062
Noncontrolling interest in consolidated joint venture	$ 2,100													2,100
Repurchase of common stock, net of offering costs (in shares)	0
Net income	$ 424,190						4,508					21,069		(101)									398,714
Other comprehensive income	(1,911)											(178)										(1,733)
Distributions to Operating Partnership units held by noncontrolling interests	(28,043)						(4,667)					(23,376)
Dividends paid on common stock	(438,783)																						(438,783)
Balance, end of period at Jun. 30, 2023	$ 4,035,407						222,940					553,610		3,079	$ 1,351			3,383,303				47,065	(175,941)
Balance, end of period (in shares) at Jun. 30, 2023	135,058,897														135,058,897
Balance, beginning of period at Mar. 31, 2023	$ 4,032,701						222,940					554,015		2,413	$ 1,350			3,376,458				35,081	(159,556)
Balance, beginning of period (in shares) at Mar. 31, 2023															135,007,280
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with share based compensation (in shares)															53,823
Issuance of common stock in connection with share based compensation	6,940														$ 1			6,939
Taxes paid upon settlement of share based compensation (in shares)															(573)
Taxes paid upon net settlement of share based compensation	(94)																	(94)
Restricted stock grants cancelled (in shares)															(1,633)
Noncontrolling interest in consolidated joint venture	709													709
Net income	215,312						2,254					10,691		(43)									202,410
Other comprehensive income	12,599											615										11,984
Distributions to Operating Partnership units held by noncontrolling interests	(13,965)						(2,254)					(11,711)
Dividends paid on common stock	(218,795)																						(218,795)
Balance, end of period at Jun. 30, 2023	$ 4,035,407						$ 222,940					$ 553,610		$ 3,079	$ 1,351			$ 3,383,303				$ 47,065	$ (175,941)
Balance, end of period (in shares) at Jun. 30, 2023	135,058,897														135,058,897